Highlights of NCCN/AUA Guidelines 2024
Siamak Daneshmand, MD, covers recent updates in bladder cancer guidelines, focusing on the 2024 NCCN and AUA recommendations.
Read More
Topic: Bladder Cancer
Role of Systemic Therapies in NMIBC
Amirali Salmasi, MD, MSCR, explores the rationale for systemic immunotherapy in non-muscle invasive bladder cancer.
Read More
Updates to Microhematuria: AUA and SUFU Guidelines Update 2025
Diane K. Newman, DNP, ANP-BC, FAUNA, FAAN, discusses the newly released 2025 AUA/SUO/SUFFU guidelines on microhematuria evaluation.
Read More
Role of CtDNA in Bladder Cancer
Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.
Read More
Role of DNA Repair Mutations in Sensitivity to Cisplatin-based Chemotherapy
Gopalkumar Iyer, MD, explores the role of genomic alterations in predicting response to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Read More
Role of PLND for High Risk Bladder Cancer
Bernard H. Bochner, MD, FACS, examines the extent of lymph node dissection in bladder cancer surgery and its impact on oncologic outcomes.
Read More
Erdafitinib Update – Metastatic Urothelial Cancer
Arlene O. Siefker-Radtke, MD, explores the evolving role of erdafitinib in treating FGFR3-altered urothelial carcinoma.
Read More
UTUC Staging, Diagnosis, Intraureteralpelvis Therapy, Endoscopic Management
Jennifer A. Linehan, MD, examines strategies for managing upper tract UTUC, highlighting diagnosis, staging, and treatment selection.
Read More
BCG Unresponsive Intravesical Therapy
Piyush K. Agarwal, MD, explores the evolving landscape of treatments for BCG-unresponsive bladder cancer.
Read More
Perioperative Chemotherapy for Upper Tract Urothelial Cancer
Robert Dreicer, MD, MS, MACP, FASCO, highlights the complexities of managing high-grade urothelial carcinoma of the upper tract.
Read More
MRI-Assisted Radiosurgery (MARS) Management of High Risk and Recurrent Prostate Cancer
Steven J. Frank, MD, FACR, FABS, FASTRO, discusses advancements in MRI-assisted radiosurgery (MARS) for prostate cancer.
Read More
Changing Paradigm of First Line Therapy in Locally Advanced Metastatic Bladder Cancer
Parminder Singh, MD, explores the evolving treatment for bladder cancer, emphasizing advancements over the past decade.
Read More